Plasma Levels of Chlorpromazine in Schizophrenia
- 1 September 1978
- journal article
- review article
- Published by American Medical Association (AMA) in Archives of General Psychiatry
- Vol. 35 (9) , 1081
- https://doi.org/10.1001/archpsyc.1978.01770330055004
Abstract
• Measurement of chlorpromazine and metabolite levels in the blood has not yet developed such that it can help the clinician. Apart from their chemistry, the clinical aspects of the experimental design of most studies leave much to be desired, so that it is not possible to draw any overall conclusions about the relationship between chlorpromazine blood levels and clinical outcome from the data currently available.Measurement of response to a single test dose may prove potentially more fruitful in predicting outcome and in establishing drug and dosage choice for a given patient than simple attempts to correlate sustained dosage levels with clinical response.For chlorpromazine, indeed for any drug, it would seem wise in the first instance to focus clinically well-designed studies on the parent substance, rather than launching into more costly, but clinically unsophisticated, studies of its metabolites.Keywords
This publication has 5 references indexed in Scilit:
- Thymoleptic and Neuroleptic Drug Plasma Levels in Psychiatry: Current StatusPublished by Elsevier ,1976
- Prediction of response to chlorpromazine treatment in schizophrenicsPsychopharmacology, 1975
- THE RELATIONSHIP OF PLASMA CHLORPROMAZINE TO ITS 7‐HYDROXY AND SULPHOXIDE METABOLITES IN A LARGE POPULATION OF CHRONIC SCHIZOPHRENICSBritish Journal of Clinical Pharmacology, 1974
- Effects of mode of management on plasma chlorpromazine in psychiatric patientsClinical Pharmacology & Therapeutics, 1973
- Plasma levels of chlorpromazine and some of its relatively non-polar metabolites in psychiatric patientsLife Sciences, 1967